• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Health Tip: Preventing Child Burns

drugsJuly 08, 2019

Tag: Child , burn , prevent

Every day, more than 300 children are treated in emergency rooms for burn-related injuries, says the U.S. Centers for Disease Control and Prevention.

To help prevent your child from being burned, the CDC suggests:

Install and maintain smoke alarms at home.

Supervise children's use of stoves, ovens and microwaves.

Set your water heater's thermostat to under 120 degrees Fahrenheit.

Never leave food unattended on the stove.

Have a fire escape plan.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Previous:How Protect Against Short- and Long-Term Sun Damage

Next:Study finds common cold virus could help kill bladder cancer tumours

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Health Tip: Preventing Child Burns | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

Child-Resistant Foil

Child-Resistant Foil
fat burner gummies

fat burner gummies
Human Serum Albumin for Extensive Burns

Human Serum Albumin for Extensive Burns
28mm crc cap child resistant cap for liquid bottle

28mm crc cap child resistant cap for liquid bottle
Vinburnine

Vinburnine
Identification Band (Adult, Children)

Identification Band (Adult, Children)
CRN Snap on Nasal Spray Child resistant spray pump with bottle accept customized

CRN Snap on Nasal Spray Child resistant spray pump with bottle accept customized
Child proof Tablet bottles with DMF#

Child proof Tablet bottles with DMF#
Human Immunoglobulin (pH4) for Intravenous Injection to prevent measles and infectious hepatitis

Human Immunoglobulin (pH4) for Intravenous Injection to prevent measles and infectious hepatitis
JRF Series Coal Burnt Hot Air Furnace

JRF Series Coal Burnt Hot Air Furnace

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service